Conrad, N. ., Molenberghs, G. ., Verbeke, G. ., Zaccardi, F. ., Lawson, C. ., Friday, J. M., … McMurray, J. J. V. (2024). Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study. Bmj, 385, e078523. http://doi.org/10.1136/bmj-2023-078523
N. Sattar
First name
N.
Last name
Sattar
Ferguson, L. D., Molenberghs, G. ., Verbeke, G. ., Rahimi, K. ., Rao, S. ., McInnes, I. B., … Conrad, N. . (2024). Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatol, 6, e156-e167. http://doi.org/10.1016/s2665-9913(23)00338-7
Carey, I. M., Critchley, J. A., U, A. R. C., Cook, D. G., DeWilde, S. ., Limb, E. S., … Harris, T. . (2024). Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data. Diabetes Res Clin Pract, 111641. http://doi.org/10.1016/j.diabres.2024.111641
Conrad, N. ., Misra, S. ., . Y. Verbakel, J. ., Verbeke, G. ., Molenberghs, G. ., Taylor, P. N., … Cambridge, G. . (2023). Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. http://doi.org/10.1016/s0140-6736(23)00457-9
Dennis, J. M., Young, K. G., McGovern, A. P., Mateen, B. A., Vollmer, S. J., Simpson, M. D., … Shields, B. M. (2022). Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study. Lancet Digit Health, 4, e873-e883. http://doi.org/10.1016/s2589-7500(22)00174-1
Wright, A. K., Carr, M. J., Kontopantelis, E. ., Leelarathna, L. ., Thabit, H. ., Emsley, R. ., … Rutter, M. K. (2022). Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc21-1113
Wright, A. K., Kontopantelis, E. ., Emsley, R. ., Buchan, I. ., Sattar, N. ., Rutter, M. K., & Ashcroft, D. M. (2017). Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups. Diabetes Care. http://doi.org/10.2337/dc16-1616
Dennis, J. M., Henley, W. E., Weedon, M. N., Lonergan, M. ., Rodgers, L. R., Jones, A. G., … Hattersley, A. T. (2018). Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data. Diabetes Care. http://doi.org/10.2337/dc18-0344
Dennis, J. M., Shields, B. M., Hill, A. V., Knight, B. A., McDonald, T. J., Rodgers, L. R., … Jones, A. G. (2018). Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy. Diabetes Care. http://doi.org/10.2337/dc17-1827
Dennis, J. M., Henley, W. E., McGovern, A. P., Farmer, A. J., Sattar, N. ., Holman, R. R., … Jones, A. G. (2019). Time trends in prescribing of type 2 diabetes drugs, glycemic response and risk factors: a retrospective analysis of primary care data, 2010-2017. Diabetes Obes Metab. http://doi.org/10.1111/dom.13687